Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva M Hoekstra

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Critical Care (London, England)|December 15, 2020
Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomesJudith van Paassen, Jeroen S Vos, Eva M Hoekstra, et al.
Journal of Scleroderma and Related Disorders|November 4, 2024
Troponin I levels in systemic sclerosis patients with myocardial involvementEva M Hoekstra, Sophie Ie Liem, Saad Ahmed, et al.
Rheumatology (Oxford, England)|April 20, 2022
The effect of silver fibre gloves on Raynaud's phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trialSophie I E Liem, Eva M Hoekstra, Femke Bonte-Mineur, et al.
RMD Open|November 11, 2025
High-intensity interval and resistance training programme improves pain and fatigue outcomes in people with systemic sclerosis: a European multicentre randomised controlled trialAlexandros Mitropoulos, Kasper Yde Jensen, Evangelia Kouidi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2025
Response to Chepy et al. and Akbarzadeh et alWieke M van Oostveen, Eva M Hoekstra, E W Nivine Levarht, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 25, 2024
Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin-1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic SclerosisWieke M van Oostveen, Eva M Hoekstra, E W Nivine Levarht, et al.
RMD Open|July 15, 2025
Value of the 6 min walk test in detecting cardiopulmonary involvement in patients with systemic sclerosisSaad Ahmed, Sophie I E Liem, Jacopo Ciaffi, et al.
Rheumatology (Oxford, England)|February 15, 2026
Can we use patient reported outcomes for remote monitoring in SSc?Eva M Hoekstra, Katherine E van der Wouden, Queeny S R Madari, et al.
RMD Open|October 16, 2025
Autoantibodies directed against the angiotensin II type 1 receptor and the endothelin-1 type A receptor in patients with systemic sclerosisKatherine E van der Wouden, Saad Ahmed, Wieke M van Oostveen, et al.
RMD Open|May 21, 2024
Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohortJacopo Ciaffi, Sophie I E Liem, Suzanne Cannegieter, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Critical Care (London, England)|December 15, 2020
Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomesJudith van Paassen, Jeroen S Vos, Eva M Hoekstra, et al.
Journal of Scleroderma and Related Disorders|November 4, 2024
Troponin I levels in systemic sclerosis patients with myocardial involvementEva M Hoekstra, Sophie Ie Liem, Saad Ahmed, et al.
Rheumatology (Oxford, England)|April 20, 2022
The effect of silver fibre gloves on Raynaud's phenomenon in patients with systemic sclerosis: a double-blind randomized crossover trialSophie I E Liem, Eva M Hoekstra, Femke Bonte-Mineur, et al.
RMD Open|November 11, 2025
High-intensity interval and resistance training programme improves pain and fatigue outcomes in people with systemic sclerosis: a European multicentre randomised controlled trialAlexandros Mitropoulos, Kasper Yde Jensen, Evangelia Kouidi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2025
Response to Chepy et al. and Akbarzadeh et alWieke M van Oostveen, Eva M Hoekstra, E W Nivine Levarht, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 25, 2024
Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin-1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic SclerosisWieke M van Oostveen, Eva M Hoekstra, E W Nivine Levarht, et al.
RMD Open|July 15, 2025
Value of the 6 min walk test in detecting cardiopulmonary involvement in patients with systemic sclerosisSaad Ahmed, Sophie I E Liem, Jacopo Ciaffi, et al.
Rheumatology (Oxford, England)|February 15, 2026
Can we use patient reported outcomes for remote monitoring in SSc?Eva M Hoekstra, Katherine E van der Wouden, Queeny S R Madari, et al.
RMD Open|October 16, 2025
Autoantibodies directed against the angiotensin II type 1 receptor and the endothelin-1 type A receptor in patients with systemic sclerosisKatherine E van der Wouden, Saad Ahmed, Wieke M van Oostveen, et al.
RMD Open|May 21, 2024
Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohortJacopo Ciaffi, Sophie I E Liem, Suzanne Cannegieter, et al.
Pageof 2